The model simulations, via reduction in FH and CD59, reflect the mechanistic basis of complement activation in diseases such as atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). The gene discussed is CD59; the disease is atypical hemolytic-uremic syndrome.